Response: The Company respectfully acknowledges the Staff’s comment and advises the Staff that it
believes its current presentation of the Schedule of Investments is the most useful presentation for its
investors. The Company’s investment strategy involves making multiple types of investments (including
debt and equity investments) in most of its portfolio companies, and therefore the Company believes that
grouping these various investments together for each portfolio company is the best presentation to allow
investors to understand the Company’s investments in each portfolio company. The Schedule of
Investments includes a “Type of Investment” column that categorizes each investment by type, including
Secured Debt, Unsecured Debt, Preferred Equity, Preferred Stock, Common Stock, Member Units,
Preferred Member Units, Warrants and LP Interests, among others, which allows an investor to easily
identify the type of each investment held by the Company. The Company also advises the Staff that
subtotals by investment type, expressed as a percentage of the total investment portfolio, are included in
Note C to the consolidated financial statements. The Company further believes that the current
presentation of the Schedule of Investments, organized by portfolio company rather than by investment
type, is more useful to investors because the Company’s risk exposure is more company-specific than
investment type-specific.
Also consistent with the Company’s investment strategy and its election to be regulated as a business
development company, the Company primarily invests in United States-organized and based portfolio
companies. Footnote 20 to the Schedule of Investments identifies investments headquartered in the
United States and footnote 21 identifies those headquartered outside of the United States. Note C to the
consolidated financial statements in the Form 10-K further indicated that, as of December 31, 2025,
investments outside of the United States represented an immaterial portion of the Company’s portfolio at
4.1% of cost (3.1% Canada and 1.0% other) and 3.9% of fair value (2.9% Canada and 1.0% other) (see
footnote 3 to the Schedule of Investments). The only information required by Regulation S-X Rule
12-12, including footnote 2 and footnote 5, not currently included in the Company’s Schedule of
Investments is the subtotals of investments subdivided by the categories specified, together with their
percentage values compared to net assets, as required by footnote 5. In light of the foregoing, the
Company respectfully proposes to retain the current presentation of its Schedule of Investments, and
undertakes to add disclosure in the footnotes to the Schedule of Investments in its future SEC filings to
satisfy the requirements of footnote 5 to Regulation S-X Rule 12-12, beginning with its annual report on
Form 10-K for the fiscal year ending December 31, 2026.
4.Comment: Based on the Consolidated Schedule of Investments, several investments are past maturity as
of December 31, 2025. Please explain in correspondence (1) the status of these investments, (2) whether
these investments should be identified as non-income-producing investments with an appropriate
symbol, if not already identified as such, and (3) how some of these investments were fair valued at or
near cost.
Response: The Company acknowledges that eleven debt investments included on its Schedule of
Investments as of December 31, 2025 had maturity dates prior to such date. These investments
represented 2.5% and 0.7% of the total investment portfolio on a cost basis and a fair value basis,
respectively. The Company’s disclosures are accurate, and each of these debt investments was past due
on its principal repayment date as of December 31, 2025. Additionally, the Company provided further
disclosure in footnote 17 to the Schedule of Investments for these investments stating that the Company
was engaged in ongoing negotiations with each portfolio company regarding the maturity date and
resolution of the outstanding debt. As of the date of this letter, the Company has fully exited one and
extended the maturity date of five of the eleven debt investments that were past due on principal
repayments as of December 31, 2025. The Company is actively working toward a sale process, maturity
extension or other resolution with respect to the five remaining debt investments.